New York · 2025-2026 session
S 36 changesRelates to the labeling of mifepristone, misoprostol, and their generic alternatives
Precomputed change summary for the public. Sign in for the Diff Viewer (word-level redline, evidence, annotations, and exports).
Change log
Structural diff is ready; section summaries are not published yet. Sign in for the interactive Diff Viewer.
Word-level redline mode, annotations, and exports require a signed-in workspace. Track this bill.